Stocks
Clover Health Investments (CLOV) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -39.5% | -11.7% | -38.7% | -9.69% | -10.4% | -3.92% | ||
| Changes by years, y/y, % | +28pp | -27pp | +29pp | -1pp | -28.4% | ||||
Clover Health Investments. EBITDA margin, %
Clover Health Investments. EBITDA margin, changes, pp
Clover Health Investments (CLOV) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -6.46% | -12.8% | 2.24% | -2.55% | -2.55% | -3.92% | |
| Changes by years, y/y, % | +7pp | -8pp | +7pp | +6pp | +6pp | |||
| Changes by quarters, q/q, % | +7pp | -6pp | +15pp | -5pp | 0pp | |||
